Nearly all end stage renal disease (ESRD) patients have anemia, a reduced amount lack of red blood cells. Anemia due to ESRD is treated with medications called?erythropoiesis-stimulating agents (ESAs).?
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the End-Stage Renal Disease (ESRD) Drugs industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Calcium Succinate
Mk-3866
Pacritinib
Sanguinate
Tesidolumab
Others
Market Segment by Product Application
Hospital
Clinic
ICU
Others
Finally, the report provides detailed profile and data information analysis of leading company.
CTI BioPharma Corp
Merck & Co Inc
Novartis AG
Prolong Pharmaceuticals LLC
VESSL Therapeutics Ltd
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global End-Stage Renal Disease (ESRD) Drugs consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of End-Stage Renal Disease (ESRD) Drugs market by identifying its various subsegments.
3.Focuses on the key global End-Stage Renal Disease (ESRD) Drugs manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the End-Stage Renal Disease (ESRD) Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of End-Stage Renal Disease (ESRD) Drugs submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global End-Stage Renal Disease (ESRD) Drugs Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 End-Stage Renal Disease (ESRD) Drugs Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 End-Stage Renal Disease (ESRD) Drugs Segment by Type
2.1.1 Calcium Succinate
2.1.2 Mk-3866
2.1.3 Pacritinib
2.1.4 Sanguinate
2.1.5 Tesidolumab
2.1.6 Others
2.2 Market Analysis by Application
2.2.1 Hospital
2.2.2 Clinic
2.2.3 ICU
2.2.4 Others
2.3 Global End-Stage Renal Disease (ESRD) Drugs Market Comparison by Regions (2017-2027)
2.3.1 Global End-Stage Renal Disease (ESRD) Drugs Market Size (2017-2027)
2.3.2 North America End-Stage Renal Disease (ESRD) Drugs Status and Prospect (2017-2027)
2.3.3 Europe End-Stage Renal Disease (ESRD) Drugs Status and Prospect (2017-2027)
2.3.4 China End-Stage Renal Disease (ESRD) Drugs Status and Prospect (2017-2027)
2.3.5 Japan End-Stage Renal Disease (ESRD) Drugs Status and Prospect (2017-2027)
2.3.6 Southeast Asia End-Stage Renal Disease (ESRD) Drugs Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): End-Stage Renal Disease (ESRD) Drugs Industry Impact
2.5.1 End-Stage Renal Disease (ESRD) Drugs Business Impact Assessment - Covid-19
2.5.2 Market Trends and End-Stage Renal Disease (ESRD) Drugs Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global End-Stage Renal Disease (ESRD) Drugs Sales and Market Share by Manufacturer (2017-2022)
3.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global End-Stage Renal Disease (ESRD) Drugs Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 End-Stage Renal Disease (ESRD) Drugs Manufacturer Market Share
3.5 Top 10 End-Stage Renal Disease (ESRD) Drugs Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into End-Stage Renal Disease (ESRD) Drugs Market
3.7 Key Manufacturers End-Stage Renal Disease (ESRD) Drugs Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of End-Stage Renal Disease (ESRD) Drugs Industry Key Manufacturers
4.1 CTI BioPharma Corp
4.1.1 Compan Detail
4.1.2 CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Product Introduction, Application and Specification
4.1.3 CTI BioPharma Corp 130 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 CTI BioPharma Corp News
4.2 Merck & Co Inc
4.2.1 Compan Detail
4.2.2 Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Product Introduction, Application and Specification
4.2.3 Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 CTI BioPharma Corp News
4.3 Novartis AG
4.3.1 Compan Detail
4.3.2 Novartis AG End-Stage Renal Disease (ESRD) Drugs Product Introduction, Application and Specification
4.3.3 Novartis AG End-Stage Renal Disease (ESRD) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Novartis AG News
4.4 Prolong Pharmaceuticals LLC
4.4.1 Compan Detail
4.4.2 Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Product Introduction, Application and Specification
4.4.3 Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Prolong Pharmaceuticals LLC News
4.5 VESSL Therapeutics Ltd
4.5.1 Compan Detail
4.5.2 Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Product Introduction, Application and Specification
4.5.3 VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 VESSL Therapeutics Ltd News
5 Global End-Stage Renal Disease (ESRD) Drugs Market Segment by Big Type
5.1 Global End-Stage Renal Disease (ESRD) Drugs Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global End-Stage Renal Disease (ESRD) Drugs Sales and Market Share by Big Type (2017-2022)
5.1.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue and Market Share by Big Type (2017-2022)
5.2 Calcium Succinate Sales Growth Rate and Price
5.2.1 Global Calcium Succinate Sales Growth Rate (2017-2022)
5.2.2 Global Calcium Succinate Price (2017-2022)
5.3 Mk-3866 Sales Growth Rate and Price
5.3.1 Global Mk-3866 Sales Growth Rate (2017-2022)
5.3.2 Global Mk-3866 Price (2017-2022)
5.4 Pacritinib Sales Growth Rate and Price
5.4.1 Global Pacritinib Sales Growth Rate (2017-2022)
5.4.2 Global Pacritinib Price (2017-2022)
5.5 Sanguinate Sales Growth Rate and Price
5.5.1 Global Sanguinate Sales Growth Rate (2017-2022)
5.5.2 Global Sanguinate Price (2017-2022)
5.6 Tesidolumab Sales Growth Rate and Price
5.6.1 Global Tesidolumab Sales Growth Rate (2017-2022)
5.6.2 Global Tesidolumab Price (2017-2022)
5.7 Others Sales Growth Rate and Price
5.7.1 Global Others Sales Growth Rate (2017-2022)
5.7.2 Global Others Price (2017-2022)
6 Global End-Stage Renal Disease (ESRD) Drugs Market Segment by Big Application
6.1 Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Big Application (2017-2022)
6.2 Hospital Sales Growth Rate (2017-2022)
6.3 Clinic Sales Growth Rate (2017-2022)
6.4 ICU Sales Growth Rate (2017-2022)
6.5 Others Sales Growth Rate (2017-2022)
7 Global End-Stage Renal Disease (ESRD) Drugs Forecast
7.1 Global End-Stage Renal Disease (ESRD) Drugs Revenue, Sales and Growth Rate (2022-2027)
7.2 End-Stage Renal Disease (ESRD) Drugs Market Forecast by Regions (2022-2027)
7.2.1 North America End-Stage Renal Disease (ESRD) Drugs Market Forecast (2022-2027)
7.2.2 Europe End-Stage Renal Disease (ESRD) Drugs Market Forecast (2022-2027)
7.2.3 China End-Stage Renal Disease (ESRD) Drugs Market Forecast (2022-2027)
7.2.4 Japan End-Stage Renal Disease (ESRD) Drugs Market Forecast (2022-2027)
7.2.5 Southeast Asia End-Stage Renal Disease (ESRD) Drugs Market Forecast (2022-2027)
7.2.6 Other Regions End-Stage Renal Disease (ESRD) Drugs Market Forecast (2022-2027)
7.3 End-Stage Renal Disease (ESRD) Drugs Market Forecast by Type (2022-2027)
7.3.1 Global End-Stage Renal Disease (ESRD) Drugs Sales Forecast by Type (2022-2027)
7.3.2 Global End-Stage Renal Disease (ESRD) Drugs Market Share Forecast by Type (2022-2027)
7.4 End-Stage Renal Disease (ESRD) Drugs Market Forecast by Application (2022-2027)
7.4.1 Global End-Stage Renal Disease (ESRD) Drugs Sales Forecast by Application (2022-2027)
7.4.2 Global End-Stage Renal Disease (ESRD) Drugs Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 End-Stage Renal Disease (ESRD) Drugs Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 End-Stage Renal Disease (ESRD) Drugs Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture End-Stage Renal Disease (ESRD) Drugs
Figure Market Concentration Ratio and Market Maturity Analysis of End-Stage Renal Disease (ESRD) Drugs
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global End-Stage Renal Disease (ESRD) Drugs Market Size by Big Type
Figure Global Market Share of End-Stage Renal Disease (ESRD) Drugs by Big Type in 2021
Figure Calcium Succinate Picture (2017-2022)
Figure Mk-3866 Picture (2017-2022)
Figure Pacritinib Picture (2017-2022)
Figure Sanguinate Picture (2017-2022)
Figure Tesidolumab Picture (2017-2022)
Global End-Stage Renal Disease (ESRD) Drugs Market Size by Big Application
Table Global End-Stage Renal Disease (ESRD) Drugs Market Size by Application
Figure Global End-Stage Renal Disease (ESRD) Drugs Market Share by Big Application in 2021
Figure Hospital Picture
Figure Clinic Picture
Figure ICU Picture
Figure Others Picture
Table Global End-Stage Renal Disease (ESRD) Drugs Comparison by Regions (M USD) (2017-2027)
Figure Global End-Stage Renal Disease (ESRD) Drugs Market Size (Million US$) (2017-2027)
Figure North America End-Stage Renal Disease (ESRD) Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe End-Stage Renal Disease (ESRD) Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure China End-Stage Renal Disease (ESRD) Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan End-Stage Renal Disease (ESRD) Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia End-Stage Renal Disease (ESRD) Drugs Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and End-Stage Renal Disease (ESRD) Drugs Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global End-Stage Renal Disease (ESRD) Drugs Sales by Manufacturer (2017-2022)
Figure Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Manufacturer in 2021
Table Global End-Stage Renal Disease (ESRD) Drugs Revenue by Manufacturer (2017-2022)
Figure Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Manufacturer in 2021
Table Global End-Stage Renal Disease (ESRD) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 End-Stage Renal Disease (ESRD) Drugs Manufacturer (Revenue) Market Share in 2021
Figure Top 10 End-Stage Renal Disease (ESRD) Drugs Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into End-Stage Renal Disease (ESRD) Drugs Market
Table Key Manufacturers End-Stage Renal Disease (ESRD) Drugs Product Type
Table Mergers & Acquisitions Planning
Table CTI BioPharma Corp Company Profile
Table End-Stage Renal Disease (ESRD) Drugs Product Introduction, Application and Specification of CTI BioPharma Corp
Table End-Stage Renal Disease (ESRD) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Merck & Co Inc Company Profile
Table End-Stage Renal Disease (ESRD) Drugs Product Introduction, Application and Specification of Merck & Co Inc
Table End-Stage Renal Disease (ESRD) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Merck & Co Inc Recent Development
Table Novartis AG Company Profile
Table End-Stage Renal Disease (ESRD) Drugs Product Introduction, Application and Specification of Novartis AG
Table End-Stage Renal Disease (ESRD) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Novartis AG Main Business
Table Novartis AG Recent Development
Table Prolong Pharmaceuticals LLC Company Profile
Table End-Stage Renal Disease (ESRD) Drugs Product Introduction, Application and Specification of Prolong Pharmaceuticals LLC
Table End-Stage Renal Disease (ESRD) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Prolong Pharmaceuticals LLC Main Business
Table Prolong Pharmaceuticals LLC Recent Development
Table Prolong Pharmaceuticals LLC Main Business
Table Prolong Pharmaceuticals LLC Recent Development
Table VESSL Therapeutics Ltd Company Profile
Table End-Stage Renal Disease (ESRD) Drugs Product Introduction, Application and Specification of VESSL Therapeutics Ltd
Table End-Stage Renal Disease (ESRD) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table VESSL Therapeutics Ltd Main Business
Table VESSL Therapeutics Ltd Recent Development
Figure Global End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2017-2022)
Figure Global End-Stage Renal Disease (ESRD) Drugs Revenue and Growth Rate (2017-2022)
Table Global End-Stage Renal Disease (ESRD) Drugs Sales by Regions (2017-2022)
Figure Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Regions in 2021
Table Global End-Stage Renal Disease (ESRD) Drugs Revenue by Regions (2017-2022)
Figure Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Regions in 2021
Figure North America End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2017-2022)
Figure Europe End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2017-2022)
Figure China End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2017-2022)
Figure Japan End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2017-2022)
Figure Southeast Asia End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2017-2022)
Figure Other Regions End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2017-2022)
Table Global End-Stage Renal Disease (ESRD) Drugs Sales by Big Type (2017-2022)
Table Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Big Type (2017-2022)
Figure Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Big Type in 2019
Table Global End-Stage Renal Disease (ESRD) Drugs Revenue by Big Type (2017-2022)
Table Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Big Type (2017-2022)
Table Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Big Type in 2019
Figure Global Calcium Succinate Sales Growth Rate (2017-2022)
Figure Global Calcium Succinate Price (2017-2022)
Figure Global Mk-3866 Sales Growth Rate (2017-2022)
Figure Global Mk-3866 Price (2017-2022)
Figure Global Pacritinib Sales Growth Rate (2017-2022)
Figure Global Pacritinib Price (2017-2022)
Figure Global Sanguinate Sales Growth Rate (2017-2022)
Figure Global Sanguinate Price (2017-2022)
Figure Global Others Sales Growth Rate (2017-2022)
Table Global End-Stage Renal Disease (ESRD) Drugs Sales by Big Application (2017-2022)
Table Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Big Application (2017-2022)
Figure Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Big Application in 2019
Figure Global Hospital Sales Growth Rate (2017-2022)
Figure Global Clinic Sales Growth Rate (2017-2022)
Figure Global ICU Sales Growth Rate (2017-2022)
Figure Global Others Sales Growth Rate (2017-2022)
Figure Global End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2022-2027)
Figure Global End-Stage Renal Disease (ESRD) Drugs Revenue and Growth Rate (2022-2027)
Table Global End-Stage Renal Disease (ESRD) Drugs Sales Forecast by Regions (2022-2027)
Table Global End-Stage Renal Disease (ESRD) Drugs Market Share Forecast by Regions (2022-2027)
Figure North America Sales End-Stage Renal Disease (ESRD) Drugs Market Forecast (2022-2027)
Figure Europe Sales End-Stage Renal Disease (ESRD) Drugs Market Forecast (2022-2027)
Figure China Sales End-Stage Renal Disease (ESRD) Drugs Market Forecast (2022-2027)
Figure Japan Sales End-Stage Renal Disease (ESRD) Drugs Market Forecast (2022-2027)
Figure Southeast Asia Sales End-Stage Renal Disease (ESRD) Drugs Market Forecast (2022-2027)
Figure Other Regions Sales End-Stage Renal Disease (ESRD) Drugs Market Forecast (2022-2027)
Table Global End-Stage Renal Disease (ESRD) Drugs Sales Forecast by Type (2022-2027)
Table Global End-Stage Renal Disease (ESRD) Drugs Market Share Forecast by Type (2022-2027)
Table Global End-Stage Renal Disease (ESRD) Drugs Sales Forecast by Application (2022-2027)
Table Global End-Stage Renal Disease (ESRD) Drugs Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of End-Stage Renal Disease (ESRD) Drugs
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America End-Stage Renal Disease (ESRD) Drugs Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America End-Stage Renal Disease (ESRD) Drugs Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe End-Stage Renal Disease (ESRD) Drugs Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe End-Stage Renal Disease (ESRD) Drugs Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan End-Stage Renal Disease (ESRD) Drugs Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan End-Stage Renal Disease (ESRD) Drugs Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China End-Stage Renal Disease (ESRD) Drugs Production (K Units) Growth Rate Forecast (2021-2025)
Figure China End-Stage Renal Disease (ESRD) Drugs Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
CTI BioPharma Corp
Merck & Co Inc
Novartis AG
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)